Senior Director, Health Economics & Outcomes Research (HEOR)

About the Company

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company focused on developing innovative solutions for patients and healthcare providers in the fields of Critical Care and Infectious Diseases. Our mission is to deliver innovative, life-saving medicines for serious unmet medical conditions, driving a sustainable business for the long term. Patients are at the center of everything we do, fostering an entrepreneurial culture that encourages innovation, collaboration, and a relentless commitment to those we serve.

Our products marketed in the U.S. include:

• GIAPREZA® (angiotensin II): A vasoconstrictor to increase blood pressure in adults with septic or other distributive shock.
• XACDURO® (sulbactam for injection; durlobactam for injection): A treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex in adults.
• XERAVA® (eravacycline): A broad-spectrum antibiotic for complicated intra-abdominal infections (cIAI).
• ZEVTERA® (ceftobiprole): An advanced-generation cephalosporin antibiotic for adult patients with Staphylococcus aureus bloodstream infections (bacteremia), including right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) in adults and pediatric patients (3 months to less than 18 years old).
• Nuzolvence® (zoliflodacin): A first-in-class, single-dose oral antibiotic for uncomplicated urogenital gonorrhea in adults and adolescents 12 years of age and older weighing at least 35 kg.

About the Role

Reporting to the VP, Market Access, the Senior Director, Health Economics & Outcomes Research (HEOR) leads the development and execution of high-quality HEOR strategic activities to support optimal reimbursement and market access. This role focuses on delivering robust evidence that demonstrates product value, engaging with key external stakeholders, and partnering cross-functionally to impact business objectives. The Senior Director provides strategic leadership for evidence generation and value demonstration initiatives while serving as a trusted partner across the organization.

Responsibilities

• Provide strategic leadership and HEOR expertise across the organization to inform market access, pricing, reimbursement, and evidence-generation strategies.
• Monitor the evolving HEOR, payer, and reimbursement landscape to identify emerging trends, risks, and opportunities that may impact IST’s products.
• Design and execute HEOR strategies that demonstrate product value to U.S. hospital systems and payer formulary decision-makers, supporting commercialization, including reimbursement and pricing.
• Partner with Market Access and Commercial Leads to identify HEOR evidence needs across the product lifecycle, business development planning, and product commercialization.
• Collaborate with contract strategy and analytics to develop innovative value-based contracting approaches for use with reimbursement decision-makers (pharmacy, medical, and quality groups).
• Build strong relationships with external stakeholders, including hospital quality and outcomes groups.
• Lead economic model development (cost calculators, budget impact models) and customer presentations to formulary decision-makers in collaboration with key account teams.
• Lead various database analyses such as patient registry data, epidemiologic research, retrospective claims, and contribute to observational studies.
• Partner with Medical Affairs to provide evidence generation needs and reimbursement requirements for clinical projects.
• Lead health economics publication and communication strategies, including presentations at external conferences.
• Assist Marketing and Market Access in the development of training materials and modules related to health economic messages.
• Undertake in-house economic studies and related activities such as literature reviews and modeling where appropriate.

Requirements

• Advanced degree (Ph.D., Pharm.D., M.P.H., M.S., or M.D.) in Public Health, Health Economics, Epidemiology, Medicine, Pharmacoeconomics, Pharmacy Administration, Pharmacy, or a related scientific field.
• 10+ years of experience in health economics and/or outcomes research within the pharmaceutical or biotechnology industry.
• Experience with hospital antibiotic and critical care products is preferred.
• Experience interacting with hospitals and/or payer decision-makers, with a strong understanding of the U.S. reimbursement environment, including the submission of health economics, pricing dossiers, and/or reimbursement dossiers.

Skills

• Proven ability to develop health economic strategies that support U.S. reimbursement with a demonstrated track record of success.
• Credible, collaborative, and team-oriented HEOR/RWE leader with executive presence, strong communication skills, and a strategic mindset.
• Strong business acumen with demonstrated ability to influence internal and external stakeholders, including customers.
• Strong analytical and problem-solving skills with the ability to adapt to changing priorities and deadlines.
• Excellent planning, organization, and time management skills, with the ability to prioritize and manage multiple projects.
• Demonstrated ability to thrive in a fast-paced, dynamic, and growing biotechnology environment, with flexibility to adapt to evolving business needs and priorities.